A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)

Clinical trial NCT00642902 · TERMINATED

Trial details

NCT number: NCT00642902
Sponsor: EMD Serono
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2008-04-01
Primary completion: 2009-09-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.